Topic: Pharmacogenetic Testing for GI Patients
Wednesday, December 1, 2021
7:00 AM - 8:00 AM
Emily Cicali, Pharm.D
Clinical Assistant Professor, Department of Pharmacotherapy & Translational Research
University of Florida College of Pharmacy
Upon completion of the presentation, participants will be able to:
1. Describe the pharmacogenetics evidence for CYP2C19-guided proton pump inhibitors (PPIs).
2. Identify how to order CYP2C19 test and where to find results.
3. Apply the implications of having a CYP2C19 variant in a patient case.
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the Activity.
Emily Cicali, Pharm.D has disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
For additional information, contact Jessica McDonald-Jazrawi (904) 244-3092 email@example.com.